Clinical Value of Cxbladder to Feature at UAA 2025
11th August 2025
New clinical evidence demonstrating Cxbladder’s clinical value in hematuria evaluation and surveillance is set to be presented at the 22nd Urological Association of Asia Congress in Taipei, Taiwan, 14-17 August. Read More
Cxbladder Bulletin - July 2025
22nd July 2025
Pacific Edge invites you to read the July 2025 edition of the Cxbladder Bulletin clinician newsletter. Read More
Medicare Coverage Update for US Cxbladder Customers
29th April 2025
Novitas has finalized an LCD for Genetic Testing in Oncology that removed coverage for Medicare beneficiaries for Cxbladder tests effective on April 24, 2025. In this update we discuss our response and what this means for US Cxbladder customers going forward. Read More
Cxbladder Bulletin - April 2025
24th April 2025
Pacific Edge invites you to read the April 2025 edition of the Cxbladder Bulletin clinician newsletter. Read More
Cxbladder's Clinical Utility in Focus at AUA 2025
23rd April 2025
Recognition of Cxbladder’s clinical and economic value in evaluating patients presenting with hematuria is set to gain momentum at the American Urological Association’s (AUA) Annual Meeting, April 26–29 in Las Vegas. Read More
Cxbladder Guideline Inclusion to Feature at SESAUA
11th March 2025
The inclusion of Cxbladder Triage in a February 2025 amendment to the American Urology Association (AUA) Microhematuria Guideline is set to headline a symposium at the Annual Meeting of the Southeastern Section of the AUA (SESAUA) to be held 12-15 March in Nashville, Tennessee. Read More
Cxbladder Incorporated into AUA/SUFU Microhematuria Guideline
28th February 2025
Pacific Edge today announces the American Urological Association (AUA) has included Cxbladder Triage in an amendment to its clinical guideline for the management of patients presenting with microhematuria. Read More